Patriot Scientific Corporation Files Quarterly Report
CARLSBAD, Calif., Oct. 15, 2013
CARLSBAD, Calif., Oct. 15, 2013 /PRNewswire/ --Patriot Scientific Corporation
(OTCBB: PTSC) today announced it has filed its Report on Form 10-Q with the
U.S. Securities and Exchange Commission for the quarterly period ended August
31, 2013. The Report can be found on the SEC's website at
Earlier this month Patriot announced that it had won its patent infringement
lawsuit against HTC Corporation. In litigation before the United States
District Court for the Northern District of California, HTC was found to
infringe multiple claims within Patriot's US 5,809,336 patent. The '336
patent is one of several patents that are part of a larger portfolio held by
Patriot, known as the Moore Microprocessor Patent (MMP) portfolio™.
In addition to Patriot's success against HTC in U.S. District Court, the MMP
portfolio has survived 17 re-examination challenges before the USPTO. "We
look forward to these clear validations of the MMP portfolio to have now paved
the way for future licensing activity and operating returns commensurate with
the portfolio's broad applicability in the digital marketplace", stated Cliff
Flowers, Patriot's Interim Chief Executive Officer.
About Patriot Scientific Corporation
Headquartered in Carlsbad, California, Patriot Scientific Corporation is the
co-owner of the Moore Microprocessor Patent Portfolio™. For more information
on PTSC, visit www.ptsc.com.
About the MMP Portfolio™
The MMP Portfolio includes US patents as well as their European and Japanese
counterparts, which cover techniques that enable higher performance and lower
cost designs essential to consumer and commercial digital systems ranging from
PCs, cell phones and portable music players to communications infrastructure,
medical equipment and automobiles.
Safe Harbor Statement: Statements herein which are not purely historical,
including statements regarding Patriot Scientific Corporation's intentions,
hopes, beliefs, expectations, representations, projections, plans or
predictions of the future are forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. The forward-looking
statements involve risks and uncertainties including, but not limited to, the
risk that the recently filed actions and litigation strategy may not be
successful and the risks and uncertainties relating to the future of our MMP
joint-venture. It is important to note that the company's actual results
could differ materially from those in any such forward-looking statements.
Factors that could cause actual results to differ materially include, but are
not limited to, risks and uncertainties associated with the effect of changing
economic conditions, trends in the products markets, variations in the
company's cash flow, market acceptance risks, patent litigation, technical
development risks, and seasonality. Our business could be affected by a
number of other factors, including the risk factors listed from time to time
in the company's SEC reports including, but not limited to, the annual report
on Form 10-K for the year ended May 31, 2013 and the quarterly report on Form
10-Q for the period ended August 31, 2013. The company cautions investors not
to place undue reliance on the forward-looking statements contained herein.
Patriot Scientific Corporation disclaims any obligation, and does not
undertake to update or revise any forward-looking statements made herein.
Patriot Investor Relations
SOURCE Patriot Scientific Corporation
Press spacebar to pause and continue. Press esc to stop.